Email
AstraZeneca sued over jab: could it be down to a misunderstanding of how risk is calculated?
| From | TradeBriefs CEO Picks <[email protected]> |
| Subject | AstraZeneca sued over jab: could it be down to a misunderstanding of how risk is calculated? |
| Date | November 15, 2023 5:55 PM |
Links have been removed from this email. Learn more in the FAQ.
Message Analysis
- Sender: n/a
- Political Party: n/a
- Country: n/a
- State/Locality: n/a
- Office: n/a